---
title: Translation and Convergence for Future Medicine (미래 의학을 위한 중개 및 융합연구)
layout: post
---

# "Translation and Convergence for Future Medicine"

- 미래 의학을 위한 중개 및 융합연구
- Asan International Medical Symposium 2016
- Innovative Future for Medical Science & Technology -
- 2016년 6월 17일 (금) 서울아산병원 동관 6층 대강당 외
AIMS

## Plenary Session II "의료기술및 R&D 변화의최신동향"
* Chairperson :김청수(서울아산병원비뇨기과교수)

### 13:30 ~ 14:15 Lecture 1 :의료분야에서의 빅데이터 :임상연구 및 진료를 위한 애널리틱스의 활용
* Speaker: David W. Bates (Harvard University, Brigham and Women's Hospital, USA)
* Rising costs
* Moneyball, Boston red sox, walmart, watson
* Big data 1M - 1giga(human genome) - 1 peta
  * EHR, Genetics, Diagnostics, Mobile devices,
* Meaningful Use - EHR - growing.
  - https://www.healthit.gov/providers-professionals/meaningful-use-definition-objectives
  - https://healthit.gov
* Big data concepts
* Validation is important!
* Big data and research - Brigham and Women's - Pathology ePath, Immunology Big data Genomic platform
* Essential for future approach
* RPDR - New entity at partners healthcare = CMS, biobank, survey data, imaging, notes repo
* Big data in clinical care
* 5% patients ~ 50% cost
* iCMP claims-based approach - 3000 patients
* multiple parameters - wearable devices - continuous supervision on general care floors
* Adverse events
* PCORnet - not popular
* New Sources - the trajectory of mobile apps
* Literature Review - 7301 titles and abstracts
* App Review - iTunes, Google Play -> possibly useful 16
* Professional Society Review -
* Ginger.io https://ginger.io/
  * to drive better health outcomes through the use of passive mobile data and behavioral analytics.
* !!! Example projects - Predictive Modeling
* What we need to do all these
  * Analytics tools, repo, data warehouse, epic reporting (Clarity reporting database)
* Clinical data - ubiquitous
* !!!!Novel sources are most likely to provide marginal improvement - social, mobile!!!!
* Predictions / Implications
  * Transformative as the internet
  * Killer app - Google Maps

#### Questions
* 김규표 교수님 - Social media and health care
* 김청수 교수님 - Government and insurance - reasonably difficult to acquire - costly.

### 14:15 ~ 15:00 Lecture 2 :합성 항체에서 합성 단백질로
* Sachdev Sidhu (University of Toronto, Canada)
* The Donnelly Centre - From systems biology to systematic treatment
* Therapeutic antibody revolution - highly versatile, numorous diseases
* Ab-durg conjugates, fragment, bispecific, engineered cells
* Targeting cancer with antibodies
* !!! problem - small populations - boutique treatment!!!
* In vitro protein evolution
* Affinity, specificity enhanced
* Antibody molecules
* binding site of Ab
* highly optimized - automatic mutation of binding site
* Toronto Synthetic Antibody Library - highly diverse - Herceptin
* PHAGE - Genentech
* only changed the function, not others
* Functional genomics - **Large-scale, industry-quality Ab generation** - Preclinical biology | The middle was not quite available but now it's doable.
* Cancer Antibody TRAC antibodies - bacerial pathogens
* High yield and high affinity Fabs from naive library - 1394 total against 80 targets
* http://sites.utoronto.ca/sidhulab/about.html
* natural - synthetic Ab - synthetic proteins - synthesizable proteins
* D-protein therapeutics.- samll proteins synthesized entirely rom D-amino acids, Ab like affinity, specificity and stability,
* in vitro d-protein advantages - longer circulating HL than L-proteins - less immunogenicity - ersistant to metabolism in plasma

## Parallel Session I "의료분야에서의빅데이터" Chairperson :김태원(서울아산병원임상의학연구소장) [대강당]
15:20 ~ 18:00

### Lecture 1 :전자의무기록에 기반한 임상 빅데이터 연구 Alexander Turchin (Harvard University, Brigham and Women's Hospital, USA)
- Data warehouse : integrates data from multiple sources - i2b2 | ABLE | OHDSI
- who entered the data? Wrong input to public repo (DKA for 2 years!)
- Data quality
- Raynaud's syndrome - Omega3 (Failure)

### Lecture 2 : 의료분야에서의 빅데이터 분석 Tom Lawry (Microsoft Corp., USA)
- 8 seconds = Concentration time
- Analytics Convergence Zone - Clinical data, Geo/Social/Environmental data/Claims&Cost Data/Pharma&Life Sience Data, Patient & Citizen Data
- https://powerbi.microsoft.com/ko-kr/ !!!!! 반드시 사용해 볼것. 좋은 Visualization.
- http://www.ciokorea.com/news/29118

### Lecture 3 :생물기작 기반 암 오믹스 데이터 분석 기법
- speaker: 김 선 (서울대학교 생물정보연구소)
- https://sites.google.com/site/biohealthinformaticslab/sun-kim
- http://bioinfo.snu.ac.kr/main/index.php
- DNA, RNA, Protein이 중요 - Somatic mutation뿐만 아니라
- Transcriptome (RNA-sequencing data)
  - 싸고 쉽다.
  - 그에 비해 Underestimated되어 있다.
- Breast cancer
  - 가장 잘 알려진 암종.
  - 21-gene Oncotype DX !!! http://www.oncotypedx.com/
  - PAM50 - Prediction analysis of microarray by 50 gene classifier !!! - Survival 예측하는 Gold-standard
- Transcriptome Data analysis http://prosigna.com/x-us/overview/
- Pathway (context) analysis는 과연 informative한가?
  - A Critical Evaluation of Network and Pathway-Based Classifiers for Outcome Prediction in Breast Cancer (PLoS One 2012) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0034796
  - 50개를 랜덤하게 취해도 유의미하게 나왔다. 아무거나 취해도 유의미하게 만들 수 있다. (Negative result!)
  -  "Based on these results there is currently no reason to prefer prognostic classifiers based on composite features over single genes classifiers for predicting outcome in breast cancer."
  - 따라서 50개를 정할 때 기능적인 면을 고려해야 한다.
- PPI-based Pathway Decomposition !!! - 우리의 분류를 기반으로 Survival plot를 그리면 확연한 차이가 난다.
- Decomposed pathway and its activity measurement Using RNA-sequencing data
- 이러한 알고리듬으로 RNA-sequencing data 분석 (1138개의 sample을 사용)
  - TCGA data (Breast Cancer)
  - 기본적으로 information theory를 응용한 것이다.
  - Subtype과 발현량의 ranking에 따라 score를 매긴 후 distinguishing할 수 있다.
  - 클래스마다 차이가 확연한 Subnetwork A는 좋은 모델
  - 클래스마다 차이가 없으면 Subnetwork C는 나쁜 모델. 우리는 좋은 모델을 택해야 한다.
- **Top10 Regulated pathways by TF/miRNA**
- mir-30a (basal cell cycle activation) -> mir-149, let-7b, mir-30a
- Sub-network mining approach
- Experimental validation requires collaborators who enjoy new approaches.
  - 혹시 talk를 들으시고 관심있으면 Contact.

 ![](http://aims.amc.seoul.kr/asan/imageDown/homebuilder/20160527?fileName=Scientific-Program-kor.jpg)
 http://www.amc.seoul.kr/asan/academy/event/eventDetail.do?eventId=572
 http://aims.amc.seoul.kr/asan/depts/aims/E/deptMain.do
